Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) and mitochondrial electron transport chain (ETC) components represent the core machinery of cellular energy production and redox homeostasis. The ETC is composed of four primary protein complexes (Complex I-IV) and ATP synthase (Complex V) located in the inner mitochondrial membrane, which facilitate the transfer of electrons to oxygen to create a proton gradient for ATP synthesis (StatPearls, 2023). During this process, electrons can leak from the chain, primarily at Complexes I and III, reacting with molecular oxygen to form ROS such as superoxide and hydrogen peroxide (PubMed, 2021). While ROS serve as essential signaling molecules at physiological levels, their overproduction or the failure of the ETC leads to oxidative stress and mitochondrial dysfunction, which are central to the pathogenesis of neurodegenerative diseases, cardiovascular disorders, and aging (NIH, 2022). Pharmacological intervention in this system includes the use of ETC inhibitors like Metformin for metabolic control and cancer, as well as mitochondria-targeted antioxidants like MitoQ designed to mitigate localized oxidative damage (Nature Reviews Drug Discovery, 2020).
Modulation of electron flux through mitochondrial complexes I-IV, inhibition of ATP synthase, or direct scavenging of mitochondrial-derived reactive oxygen species to restore redox balance or induce apoptosis in target cells (PubMed, 2021; StatPearls, 2023).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and mitochondrial electron transport chain components (ROS/ETC).